Karyopharm Therapeutics Inc (KPTI)
1.06
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
1.05
-0.01
(-0.94%)
After-Hours: 20:00
Karyopharm Therapeutics Cash from Operations (Quarterly): -18.58M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -18.58M |
| September 30, 2023 | -29.53M |
| June 30, 2023 | -25.70M |
| March 31, 2023 | -18.91M |
| December 31, 2022 | -26.84M |
| September 30, 2022 | -28.37M |
| June 30, 2022 | -35.14M |
| March 31, 2022 | -59.20M |
| December 31, 2021 | 25.48M |
| September 30, 2021 | -23.96M |
| June 30, 2021 | -55.75M |
| March 31, 2021 | -52.89M |
| December 31, 2020 | -30.63M |
| September 30, 2020 | -44.31M |
| June 30, 2020 | -40.28M |
| March 31, 2020 | -45.01M |
| December 31, 2019 | -39.49M |
| September 30, 2019 | -36.51M |
| June 30, 2019 | -48.20M |
| March 31, 2019 | -66.62M |
| December 31, 2018 | -48.17M |
| September 30, 2018 | -38.66M |
| Date | Value |
|---|---|
| June 30, 2018 | -37.63M |
| March 31, 2018 | -34.65M |
| December 31, 2017 | -5.538M |
| September 30, 2017 | -21.75M |
| June 30, 2017 | -21.72M |
| March 31, 2017 | -24.71M |
| December 31, 2016 | -20.00M |
| September 30, 2016 | -20.33M |
| June 30, 2016 | -20.89M |
| March 31, 2016 | -23.16M |
| December 31, 2015 | -20.38M |
| September 30, 2015 | -25.33M |
| June 30, 2015 | -28.10M |
| March 31, 2015 | -20.22M |
| December 31, 2014 | -12.77M |
| September 30, 2014 | -16.23M |
| June 30, 2014 | -11.88M |
| March 31, 2014 | -10.57M |
| December 31, 2013 | -10.08M |
| September 30, 2013 | -8.899M |
| June 30, 2013 | -6.156M |
| March 31, 2013 | -5.157M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-59.20M
Minimum
Mar 2022
25.48M
Maximum
Dec 2021
-33.36M
Average
-35.14M
Median
Jun 2022
Cash from Operations (Quarterly) Benchmarks
| Geron Corp | -40.94M |
| Arbutus Biopharma Corp | -17.29M |
| Verastem Inc | -29.68M |
| Actinium Pharmaceuticals Inc | -7.49M |
| Chimerix Inc | -14.59M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 26.84M |
| Cash from Financing (Quarterly) | 0.264M |
| Free Cash Flow | -92.72M |
| Free Cash Flow Per Share (Quarterly) | -0.1619 |
| Free Cash Flow to Equity (Quarterly) | -18.80M |
| Free Cash Flow to Firm (Quarterly) | -14.89M |
| Free Cash Flow Yield | -76.59% |